Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
0.2254 EUR | -3.72% | -33.23% | -96.35% |
Nov. 23 | Orpea SA(ENXTPA:ORPDS) dropped from CAC All-Tradable Index | CI |
Nov. 23 | Orpea SA(ENXTPA:ORPDS) dropped from SBF 120 Index | CI |
Sales 2023 * | 5,009 M 5,502 M | Sales 2024 * | 5,360 M 5,887 M | Capitalization | 15.13 M 16.62 M |
---|---|---|---|---|---|
Net income 2023 * | -432 M -475 M | Net income 2024 * | -116 M -127 M | EV / Sales 2023 * | 1,56x |
Net Debt 2023 * | 7,791 M 8,558 M | Net Debt 2024 * | 7,280 M 7,996 M | EV / Sales 2024 * | 1,36x |
P/E ratio 2023 * | -0,04x | P/E ratio 2024 * | -0,13x | Employees | 76,000 |
Yield 2023 * | 5,69% | Yield 2024 * | - | Free-Float | 94.84% |
More Fundamentals
* Assessed data
More news
More recommendations
More news
1 day | +14.01% | ||
1 week | -19.73% | ||
Current month | -72.14% | ||
1 month | -73.88% | ||
3 months | -84.57% | ||
6 months | -87.49% | ||
Current year | -95.68% |
1 week
0.16
0.33

1 month
0.16
1.60

Current year
0.16
8.93

1 year
0.16
8.93

3 years
0.16
119.80

5 years
0.16
129.00

10 years
0.16
129.00

Managers | Title | Age | Since |
---|---|---|---|
Laurent Guillot
CEO | Chief Executive Officer | 54 | 2022 |
Laurent Lemaire
DFI | Director of Finance/CFO | - | 2021 |
Chief Tech/Sci/R&D Officer | - | 2022 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 65 | 2022 | |
John Glen
BRD | Director/Board Member | 64 | 2022 |
Mireille Faugère
BRD | Director/Board Member | 66 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.13% | 26 M€ | +9.30% | - | |
0.10% | 11 M€ | +2.32% | ||
0.06% | 2,627 M€ | +7.23% | - | |
0.03% | 7 M€ | +7.21% |
Date | Price | Change | Volume |
---|---|---|---|
23-11-29 | 0.2254 | -3.72% | 14 038 546 |
23-11-28 | 0.2341 | +10.95% | 13,487,440 |
23-11-27 | 0.2110 | -12.08% | 10,073,520 |
23-11-24 | 0.2400 | -20.27% | 6,554,806 |
23-11-23 | 0.3010 | -9.47% | 5,765,164 |
Real-time Euronext Paris, November 29, 2023 at 04:38 am EST
More quotes
ORPEA is the European leader in global dependency care. The group operates retirement homes, follow-up care clinics, and psychiatric clinics.
At the end of 2022, ORPEA had a network of 992 facilities (90,860 beds) located in France (358 facilities; 33,462 beds), Benelux/the United Kingdom/Ireland (193 facilities; 10,708 beds), Central Europe (237 facilities; 23,765 beds), Eastern Europe (124 facilities; 12,764 beds), the Iberian Peninsula and Latin America (79 facilities; 10,007 beds) and China (1 facility; 154 beds)
The group has a real estate portfolio of nearly 2.3 million m2 with a value of EUR 6,500 million.
Net sales are distributed geographically as follows: France/Benelux/the United Kingdom/Ireland (59.9%), Central Europe (25.6%), Eastern Europe (9.3%), Iberian Peninsula and Latin America (5.1%) and other (0.1%).
Calendar
2023-12-22
- Annual General Meeting
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy

Mean consensus
SELL
Number of Analysts
3
Last Close Price
0.2341EUR
Average target price
4.763EUR
Spread / Average Target
+1,934.40%
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. (M$) | |
---|---|---|
-95.68% | 17 M $ | |
-12.66% | 1 909 M $ | |
+27.85% | 1 166 M $ | |
-0.64% | 582 M $ | |
+48.31% | 527 M $ | |
-11.40% | 474 M $ | |
-1.99% | 314 M $ | |
-27.92% | 129 M $ | |
-15.36% | 83 M $ | |
+44.52% | 64 M $ |